NR3C2 and cardiomyopathy: Mineralocorticoid receptor (MR) activation by aldosterone can contribute to cardiac pathology by promoting cardiomyocyte death, hypertrophy, and fibrosis in DMD cardiomyopathy and other types of heart failure [149].